David S. López

Statistics

Publications

Citations

1.3K

H-Index

Active since

2004

Affiliations

The University of Texas Health Science Center at Houston(Current)

The University of Texas Medical Branch at Galveston

University of Ioannina

The University of Texas MD Anderson Cancer Center

Imperial College London

David S. López is an author at The University of Texas Health Science Center at Houston specializing in medicine, oncology, and epidemiologic methods.

ORCID

Publications per year

2004–2023

Publications

Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial

Konstantinos K. Tsilidis, Despoina Capothanassi, Naomi E. Allen et al. · Diabetes Care · 2014 · 183 citations

Medicine, Oncology, Pharmacotherapy +10

Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel

Eli I. Lev, Rajnikant Patel, Sasidhar Guthikonda et al. · Thrombosis Research · 2006 · 147 citations

Medicine, Genetics, Pharmacology +16

Body fatness and sex steroid hormone concentrations in US men: results from NHANES III

Sabine Rohrmann, Meredith S. Shiels, David S. López et al. · Cancer Causes & Control · 2011 · 107 citations · Full text

Medicine, Endocrinology, Public Health Nutrition +10

Association between endogenous sex steroid hormones and inflammatory biomarkers in US men

Konstantinos K. Tsilidis, Sabine Rohrmann, Katherine A. McGlynn et al. · Andrology · 2013 · 87 citations · Full text

Medicine, Endocrinology, Inflammation +13

Hypogonadism and the risk of rheumatic autoimmune disease

Jacques Baillargeon, Soham Al Snih, Mukaila A. Raji et al. · Clinical Rheumatology · 2016 · 75 citations

Life Sciences, Endocrinology, Autoimmunity +11

1–5 of 37